Skip to main content
      #EULAR2024 POS0467 - Periodontal disease related tot he development of #RA
      ACPA positive and negative pts.
      Tooth extract

      Bella Mehta bella_mehta

      10 months ago
      #EULAR2024 POS0467 - Periodontal disease related tot he development of #RA ACPA positive and negative pts. Tooth extraction in CCP positive pts was associated. Need tooth history in RA. @RheumNow https://t.co/b9Nb3cd0kd
      Signing off from #EULAR2024 Vienna 🇦🇹. Well done team on your hard work and comprehensive coverage 👊🏾🙌?

      Md Yuzaiful Md Yusof Yuz6Yusof

      10 months ago
      Signing off from #EULAR2024 Vienna 🇦🇹. Well done team on your hard work and comprehensive coverage 👊🏾🙌🏻 @drdavidliew @synovialjoints @AurelieRheumo @bella_mehta @DrMiniDey @Janetbirdope @drpnash @RheumKay @JointMD @andreafava @RheumNow Safe travel 🧳 ✈️🫶🏼 https://t.co/PGtaM02A6j
      Work ability is impaired in the majority of axSpA patients as measured by the WAI score. 996 patients were included with

      Dr. Antoni Chan synovialjoints

      10 months ago
      Work ability is impaired in the majority of axSpA patients as measured by the WAI score. 996 patients were included with a mean WAI score of 31.7. Overall, 28%/43% of patients were in poor/moderate work ability, were older, more often obese , had lower education level and… https://t.co/D7oFn31Of5 https://t.co/g79riND9AO
      #EULAR2024 POS0326 Multicentre cohort in Italy (N=67) showed Benralizumab and Mepolizumab 300mg (EGPA dose) exhibited a

      Md Yuzaiful Md Yusof Yuz6Yusof

      10 months ago
      #EULAR2024 POS0326 Multicentre cohort in Italy (N=67) showed Benralizumab and Mepolizumab 300mg (EGPA dose) exhibited a significant steroid-sparing effect, with MEPO300 demonstrating superior drug survival. MEPO100 (eosinophilic asthma dose) was numerically inferior @RheumNow
      EULAR

      OP0041 (2024)
      COMPARISON OF b/tsDMARDs ABOUT NON-INFLAMMATORY PAIN IN PATIENTS WITH RHEUMATOID ARTHRITIS–ANSWE

      Peter Nash drpnash

      10 months ago
      EULAR OP0041 (2024) COMPARISON OF b/tsDMARDs ABOUT NON-INFLAMMATORY PAIN IN PATIENTS WITH RHEUMATOID ARTHRITIS–ANSWER LONGITUDINAL COHORT STUDY. 25% RA have significant non-inflammatory pain https://t.co/XWnzuVMlbn @RheumNow #EULAR2024
      Reassessment of the cut-off values for ASDAS disease activity states in a large, multinational cohort of axSpA patients

      Dr. Antoni Chan synovialjoints

      10 months ago
      Reassessment of the cut-off values for ASDAS disease activity states in a large, multinational cohort of axSpA patients resulted in cut-offs largely similar to the currently endorsed cut-offs of 1.3, 2.1 and 3.5. Cut-off values between ID and LDA and between LDA and HDA, however,… https://t.co/vECCsmTggW https://t.co/XU7BQBYBdQ
      EULAR
      OP0092 (2024)
      INFECTIONS IN PATIENTS WITH RA TREATED WITH JAKi COMPARED TO bDMARDs: AN INTERNATIONAL COLLABORATI

      Peter Nash drpnash

      10 months ago
      EULAR OP0092 (2024) INFECTIONS IN PATIENTS WITH RA TREATED WITH JAKi COMPARED TO bDMARDs: AN INTERNATIONAL COLLABORATION OF REGISTERS (THE “JAK-POT” STUDY) TNF,OMA,JAK 7-10/100 pt.yr no signif diff except for zoster >30,000pts https://t.co/XWnzuVMlbn @RheumNow #EULAR2024
      #EULAR2024 highlight from Prof Pitzalis & team- synovial phosphoproteome analysis in late-stage RA identifies signal

      Mrinalini Dey DrMiniDey

      10 months ago
      #EULAR2024 highlight from Prof Pitzalis & team- synovial phosphoproteome analysis in late-stage RA identifies signalling pathways assoc with pathotype & response to RTX & TOC Study highlights active signalling pathways assoc with pathotype & drug response OP0218 @RheumNow https://t.co/RZMSgj9T6k
      New validated BASDAI cut offs. BASDAI values of <2, <4 and >6 are often applied as cut-offs between remission,

      Dr. Antoni Chan synovialjoints

      10 months ago
      New validated BASDAI cut offs. BASDAI values of <2, <4 and >6 are often applied as cut-offs between remission, low (LDA), high (HDA) and very high (VHDA) disease activity, respectively, although this remains unvalidated. The optimal BASDAI values against external criteria were… https://t.co/5cvWoddHaN https://t.co/oBwYmFsIga
      #EULAR2024 POS0234 The effect of prophylactic Septrin in ANCA #vasculitis pts treated with RTX/CyC need further characte

      Md Yuzaiful Md Yusof Yuz6Yusof

      10 months ago
      #EULAR2024 POS0234 The effect of prophylactic Septrin in ANCA #vasculitis pts treated with RTX/CyC need further characterisation. Multicentre study in Korea showed protective effect on Serious Infection btw those treated vs not. Effect was seen in the first 3mths only @RheumNow https://t.co/dCzD21589S
      ×